OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Overview Fund Activity
Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

69 hedge funds and large institutions have $259M invested in Singular Genomics Systems, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+7
Holders Change %
+11.29%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
34
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
UBS Group
Switzerland
$28.8M
2
BlackRock
BlackRock
New York
$17.9M
3
TM
Tikvah Management
North Carolina
$4.47M
4
Citadel Advisors
Citadel Advisors
Florida
$2.83M
5
PA
Perceptive Advisors
New York
$23.1M

Top Sellers

1
RCM
Revelation Capital Management
California
$14M
2
DM
Deerfield Management
New York
$41.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
$9.42M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$1.06M
5
TM
Triatomic Management
California
$1.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– -$187K -538 Closed
AGM
77
Alpine Global Management
New York
– -$135K -391 Closed
PP
78
Paloma Partners
Connecticut
– -$116K -334 Closed
CAPTRUST Financial Advisors
79
CAPTRUST Financial Advisors
North Carolina
– -$1K -3 Closed
1 2 3
4